1] Conjoint Kidney Research Laboratory, Pathology Queensland, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia [2] Department of Renal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia [3] Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
1] Conjoint Kidney Research Laboratory, Pathology Queensland, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia [2] Department of Renal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Kidney Int. 2015 Jun;87(6):1153-63. doi: 10.1038/ki.2014.407. Epub 2015 Jan 14.
Chemokines play pivotal roles in tissue recruitment and retention of leukocytes, with CX3CR1 recently identified as a chemokine receptor that selectively targets mouse kidney dendritic cells (DCs). We have previously demonstrated increased tubulointerstitial recruitment of human transforming growth factor-β (TGF-β)-producing DCs in renal fibrosis and chronic kidney disease (CKD). However, little is known about the mechanism of human DC recruitment and retention within the renal interstitium. We identified CD1c+ DCs as the predominant source of profibrotic TGF-β and highest expressors of the fractalkine receptor CX3CR1 within the renal DC compartment. Immunohistochemical analysis of diseased human kidney biopsies showed colocalization of CD1c+ DCs with fractalkine-positive proximal tubular epithelial cells (PTECs). Human primary PTEC activation with interferon-γ and tumor necrosis factor-α induced both secreted and surface fractalkine expression. In line with this, we found fractalkine-dependent chemotaxis of CD1c+ DCs to supernatant from activated PTECs. Finally, in comparison with unactivated PTECs, we showed significantly increased adhesion of CD1c+ DCs to activated PTECs via a fractalkine-dependent mechanism. Thus, TGF-β-producing CD1c+ DCs are recruited and retained in the renal tubulointerstitium by PTEC-derived fractalkine. These cells are then positioned to play a role in the development of fibrosis and progression of chronic kidney disease.
趋化因子在白细胞向组织的募集和保留中发挥着关键作用,最近发现 CX3CR1 是一种趋化因子受体,它选择性地靶向小鼠肾脏树突状细胞 (DC)。我们之前已经证明,在肾脏纤维化和慢性肾脏病 (CKD) 中,人转化生长因子-β (TGF-β) 产生的 DC 会增加肾小管间质的募集。然而,对于人 DC 在肾间质中的募集和保留机制知之甚少。我们确定 CD1c+ DC 是肾 DC 区中产生促纤维化 TGF-β 的主要来源,也是 fractalkine 受体 CX3CR1 的高表达者。对患病人类肾脏活检组织的免疫组织化学分析显示,CD1c+ DC 与 fractalkine 阳性近端肾小管上皮细胞 (PTEC) 共定位。用干扰素-γ和肿瘤坏死因子-α激活人原代 PTEC 可诱导分泌和表面 fractalkine 的表达。与此一致,我们发现 CD1c+ DC 对激活的 PTEC 上清液表现出 fractalkine 依赖性趋化性。最后,与未激活的 PTEC 相比,我们显示 CD1c+ DC 对激活的 PTEC 的黏附通过 fractalkine 依赖性机制显著增加。因此,PTEC 衍生的 fractalkine 将产生 TGF-β 的 CD1c+ DC 募集并保留在肾小管间质中。这些细胞随后被定位在纤维化的发展和慢性肾脏病的进展中发挥作用。